Huntington’s disease: novel therapeutic strategies targeting the mutant huntingtin production pathway

L'accesso ai contenuti di questo sito è riservato agli operatori del settore sanitario italiano Registrati per accedere ai contenuti
No disease-slowing treatment exists for Huntington’s disease, but its monogenic inheritance makes it an appealing candidate for the development of therapies targeting processes close to its genetic cause. Huntington’s disease is caused by CAG repeat expansions in the HTT gene, which encodes t...